Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Sotera Health Co’s stock clocked out at $17.44, up 0.40% from its previous closing price of $17.37. In other words, the price has increased by $0.40 from its previous closing price. On the day, 1.45 million shares were traded. SHC stock price reached its highest trading level at $17.49 during the session, while it also had its lowest trading level at $17.285.
Ratios:
To gain a deeper understanding of SHC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.46 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 43.18. For the most recent quarter (mrq), Quick Ratio is recorded 2.16 and its Current Ratio is at 2.38. In the meantime, Its Debt-to-Equity ratio is 4.14 whereas as Long-Term Debt/Eq ratio is at 4.10.
Upgrades & Downgrades
In the most recent recommendation for this company, BMO Capital Markets on November 13, 2025, initiated with a Outperform rating and assigned the stock a target price of $19.
On May 05, 2025, Goldman Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $17.
On December 06, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $14.Goldman initiated its Neutral rating on December 06, 2024, with a $14 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 10 ’25 when GTCR INVESTMENT XI LLC sold 12,000,000 shares for $15.65 per share. The transaction valued at 187,812,000 led to the insider holds 29,215,301 shares of the business.
WARBURG PINCUS & CO. sold 18,000,000 shares of SHC for $281,718,000 on Nov 10 ’25. The Director now owns 43,822,952 shares after completing the transaction at $15.65 per share. On Nov 10 ’25, another insider, WARBURG PINCUS & CO., who serves as the Director of the company, sold 18,000,000 shares for $15.65 each. As a result, the insider received 281,718,000 and left with 43,822,952 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SHC now has a Market Capitalization of 4954597888 and an Enterprise Value of 6934695936. As of this moment, Sotera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 90.36, and their Forward P/E ratio for the next fiscal year is 18.48. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.40. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.31 while its Price-to-Book (P/B) ratio in mrq is 9.00. Its current Enterprise Value per Revenue stands at 6.028 whereas that against EBITDA is 12.737.
Stock Price History:
The Beta on a monthly basis for SHC is 1.81, which has changed by 0.32422173 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, SHC has reached a high of $17.78, while it has fallen to a 52-week low of $9.53. The 50-Day Moving Average of the stock is 8.05%, while the 200-Day Moving Average is calculated to be 29.32%.
Shares Statistics:
It appears that SHC traded 2.30M shares on average per day over the past three months and 2487860 shares per day over the past ten days. A total of 284.09M shares are outstanding, with a floating share count of 203.78M. Insiders hold about 28.27% of the company’s shares, while institutions hold 57.49% stake in the company. Shares short for SHC as of 1763078400 were 7742768 with a Short Ratio of 3.36, compared to 1760486400 on 7248497. Therefore, it implies a Short% of Shares Outstanding of 7742768 and a Short% of Float of 5.0200000000000005.
Earnings Estimates
A comprehensive evaluation of Sotera Health Co (SHC) is underway, with the input of 8.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $0.17, with high estimates of $0.18 and low estimates of $0.17.
Analysts are recommending an EPS of between $0.84 and $0.83 for the fiscal current year, implying an average EPS of $0.84. EPS for the following year is $0.94, with 8.0 analysts recommending between $0.97 and $0.92.
Revenue Estimates
In. The current quarter, 7 analysts expect revenue to total $299.17M. It ranges from a high estimate of $299.9M to a low estimate of $298M. As of. The current estimate, Sotera Health Co’s year-ago sales were $290.2MFor the next quarter, 7 analysts are estimating revenue of $269.74M. There is a high estimate of $277.17M for the next quarter, whereas the lowest estimate is $262.36M.
A total of 7 analysts have provided revenue estimates for SHC’s current fiscal year. The highest revenue estimate was $1.16B, while the lowest revenue estimate was $1.16B, resulting in an average revenue estimate of $1.16B. In the same quarter a year ago, actual revenue was $1.1BBased on 7 analysts’ estimates, the company’s revenue will be $1.23B in the next fiscal year. The high estimate is $1.24B and the low estimate is $1.21B.
